45.84USD-1.93%Mkt Cap: 4.21B USDP/E: —Last update: 2026-06-01
Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States. The company's products include FILSPARI…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap4.21B USD
Enterprise Value4.45B USD
Revenue (TTM)536.20M USD
Gross Profit480.39M USD
Net Income (TTM)-25.55M USD
Revenue/Share5.952 USD
Last Price45.84 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees497
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)9.59
PEG—
EV/EBITDA276.74
EV/Revenue8.30
P/S8.18
P/B44.18
EPS (TTM)-0.50
EPS (Forward)4.92
52W Range
13.8892% of range48.61
52W High48.61 USD
52W Low13.88 USD
Profitability
Gross Margin97.89%
Oper. Margin-29.02%
EBITDA Margin3.00%
Profit Margin-5.21%
ROE-22.25%
ROA-4.22%
Growth
Revenue Growth55.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF37.78M USD
CapEx (TTM)58.16M USD
FCF Margin-9.54%
FCF Yield-1.22%
Net Debt62.99M USD
Net Debt/EBITDA3.92
Balance Sheet
Debt/Equity2.86
Current Ratio3.13
Quick Ratio2.82
Book Value/Sh1.068 USD
Cash/Share2.846 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)54.14 USD
Target Range43.00 USD – 60.00 USD
# Analysts14
Ownership
Shares Out.92.99M
Float86.99M
Insiders0.80%
Institutions114.03%
Short Interest
Short Ratio5.2d
Short % Float19.70%
Short % Out.15.06%
Shares Short14.01M
Short (prev mo.)12.73M
Technical
SMA 5038.23 (+19.9%)
SMA 20031.44 (+45.8%)
Beta1.14
S&P 52W Chg27.70%
Avg Vol (30d)2.10M
Avg Vol (10d)1.74M
Technical Indicators
RSI (14)65.0
MACD2.0952
MACD Signal2.0686
MACD Hist.+0.0266
BB Upper47.39 USD
BB Middle44.30 USD
BB Lower41.20 USD
BB Width13.98%
ATR (14)2.078 USD
Vol Ratio (20d)0.43x